Media Advisory - The Canadian Cancer Society, CQDM, the Cole Foundation and Oncopole grant close to $8.5 million to four researchers in Quebec to support pediatric cancer research
MONTREAL, Oct. 26, 2022 /CNW/ - The Canadian Cancer Society (CCS), the CQDM, the Cole Foundation and Oncopole invite media representatives on Wednesday, November 2 for a grant presentation to four researchers for their projects to support pediatric cancer research in Quebec.
This funding is possible through the Pediatric Cancer Research Initiative, a partnership between CCS and its partners CQDM, the Cole Foundation and Oncopole, who joined forces to fund pediatric and young adults' cancer research projects.
The press conference will be held at Courtyard Marriott Montreal Downtown in the presence of:
- Andrea Seale, CEO of the Canadian Cancer Society
- Diane Gosselin, CEO of CQDM
- Barry Cole, President of the Cole Foundation
- Carole Jabet, Scientific Director of Fonds de recherche du Québec (FRQ)
WHO: |
Canadian Cancer Society and its partners CQDM, Cole Foundation and Oncopole |
WHAT: |
Press Conference |
WHEN: |
Wednesday, November 2, 2022 from 10:30 to 11:30 am |
WHERE: |
Courtyard Marriott Montreal Downtown, 380 René-Lévesque Blvd. West in Montreal |
Boardroom: Jackie Robinson |
|
WHY: |
Announcement of the four pediatric cancer research projects to receive grants through the Pediatric Cancer Research Initiative |
SOURCE Canadian Cancer Society (National Office)
To confirm attendance or for media interviews, please contact: Brigitte Filiatrault, Brigitte Filiatrault Relations Publiques (BFRP) for Canadian Cancer Society, [email protected] / 514-702-2744
Share this article